Surgical Societies Must Lead the Way on Addressing Bias and Microaggressions Callisia N. Clarke Pancreatic Tumors 02 November 2021 Pages: 755 - 757
Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard Keith A. DelmanMeredith C. MasonMichael C. Lowe Melanoma 10 November 2021 Pages: 758 - 759
Melanoma Surgery in the Emerging Era of Effective Neoadjuvant Therapy John MiuraGiorgos Karakousis Melanoma 23 November 2021 Pages: 760 - 761
Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors Sonia CohenGenevieve M. Boland Melanoma 26 November 2021 Pages: 762 - 763
Genomic Expression Profiling in Melanoma and the Road to Clinical Practice Michael S. Sabel Melanoma 01 December 2021 Pages: 764 - 766
Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes Marc MoncrieffSarah PywellMartin Heaton Melanoma Open access 26 October 2021 Pages: 767 - 775
ASO Author Reflections: Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes Marc MoncrieffSarah PywellDavina Pawaroo ASO Author Reflections Open access 29 November 2021 Pages: 776 - 777
ASO Visual Abstract: Effectiveness of SPECT/CT Imaging for Sentinel Node Biopsy Staging of Primary Cutaneous Melanoma and Patient Outcomes Marc MoncrieffSarah PywellMartin Heaton ASO Visual Abstract 11 November 2021 Pages: 778 - 779
Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma Tina J. HiekenDaniel L. PriceMatthew S. Block Melanoma 25 November 2021 Pages: 780 - 786
ASO Author Reflections: Adding Value to Multidisciplinary Care by Incorporating Structured Surgeon Survey Assessment of the Effect of Neoadjuvant Therapies on Melanoma Operations Tina J. HiekenMara A. PiltinMatthew S. Block ASO Author Reflections 20 November 2021 Pages: 787 - 788
ASO Visual Abstract: Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma Tina J. HiekenDaniel L. PriceMatthew S. Block ASO Visual Abstract 30 November 2021 Pages: 789 - 790
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience Michael J. CarrJames SunJonathan S. Zager Melanoma 14 October 2021 Pages: 791 - 801
ASO Author Reflections: T-VEC as Salvage for Progression of Locoregionally Metastatic Melanoma After Failure of Immunotherapy Michael J. CarrJonathan S. Zager ASO Author Reflections 11 October 2021 Pages: 802 - 803
ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience Michael J. CarrJames SunJonathan S. Zager ASO Visual Abstract 24 November 2021 Pages: 804 - 805
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection Robert J. TorphyChloe FriedmanAna Gleisner Melanoma 19 September 2021 Pages: 806 - 815
ASO Author Reflections: Adjuvant Therapy for Stage III Melanoma With or Without Completion Lymph Node Dissection Robert J. TorphyMartin D. McCarterAna L. Gleisner ASO Author Reflections 24 September 2021 Pages: 816 - 817
Post-Publication Discussion: In Reply Adam C. BergerVadim Koshenkov Melanoma 01 December 2021 Pages: 818 - 819
Post-Publication Discussion: Invitation for Reply Mark S. RohDouglas S. Tylerthe Annals of Surgical Oncology Editors Melanoma 01 December 2021 Pages: 820 - 820
Data-Driven Respectful Discourse in the Society of Surgical Oncology Camille L. StewartSusanne G. WarnerMartin Heslin Global Health Services Research 26 September 2021 Pages: 821 - 826
ASO Visual Abstract: Data-Driven Respectful Discourse in the Society of Surgical Oncology Camille L. StewartSusanne G. WarnerMartin Heslin ASO Visual Abstract 29 October 2021 Pages: 827 - 827
Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort? Brian C. BrajcichBryan E. PalisHeidi Nelson Global Health Services Research 24 October 2021 Pages: 828 - 836
Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among US Counties Chelsea HerbertAlessandro ParoTimothy M. Pawlik Global Health Services Research 28 September 2021 Pages: 837 - 848
ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties Chelsea HerbertAlessandro ParoTimothy M. Pawlik ASO Author Reflections 01 October 2021 Pages: 849 - 850
ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties Chelsea HerbertAlessandro ParoTimothy M. Pawlik ASO Visual Abstract 27 October 2021 Pages: 851 - 852
Predicting Colon Cancer-Specific Survival for the Asian Population Using National Cancer Registry Data from Taiwan Han-Ching ChanChi-Cheng HuangTzu-Pin Lu Global Health Services Research 24 August 2021 Pages: 853 - 863
ASO Author Reflections: Robust Prediction Models for Colon Cancer in Asian Patients Amrita ChattopadhyayTzu-Pin Lu ASO Author Reflections 26 August 2021 Pages: 864 - 865
HIPEC Trials and the US: A Review and Call to Action Colette R. Pameijer Peritoneal Surface Malignancy 01 October 2021 Pages: 866 - 872
Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Metastases Andrei NikiforchinVadim GushchinArmando Sardi Peritoneal Surface Malignancy 21 September 2021 Pages: 873 - 882
ASO Author Reflections: What to Expect After You Resect Diaphragm During CRS/HIPEC Andrei NikiforchinMichelle SittigArmando Sardi ASO Author Reflections 19 September 2021 Pages: 883 - 884
Nomogram to Predict Incomplete Cytoreduction for Pseudomyxoma Peritonei Mingjian BaiShilong WangMan Zhang Peritoneal Surface Malignancy 03 September 2021 Pages: 885 - 892
The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma Tatsunori MiyataHiromitsu HayashiHideo Baba Hepatobiliary Tumors 30 September 2021 Pages: 893 - 902
ASO Author Reflections: Is Histologic Liver Inflammation a Predictor in Patients with Hepatocellular Carcinoma after Hepatectomy? Tatsunori MiyataHiromitsu HayashiHideo Baba ASO Author Reflections 27 August 2021 Pages: 903 - 904
Preventing Futile Liver Resection: A Risk-Based Approach to Surgical Selection in Major Hepatectomy for Colorectal Cancer Marc W. FromerCharles R. ScogginsRobert C. G. Martin II Hepatobiliary Tumors 14 September 2021 Pages: 905 - 912
Anatomic Resection for Hepatocellular Carcinoma: Prognostic Impact Assessed from Recurrence Treatment Masaaki MinagawaYoshihiro MiseAkio Saiura Hepatobiliary Tumors 21 September 2021 Pages: 913 - 921
ASO Author Reflections: Does Anatomic Resection Improve Prognosis for Hepatocellular Carcinoma? Assessment from Recurrence Treatment Masaaki MinagawaYoshihiro MiseAkio Saiura ASO Author Reflections 13 September 2021 Pages: 922 - 923
Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality Kazumasa FujitaniYukinori Kurokawathe Osaka University Clinical Research Group for Gastroenterological Surgery Hepatobiliary Tumors 03 September 2021 Pages: 924 - 932
ASO Visual Abstract: A Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate and Operative Morbidity and Mortality Kazumasa FujitaniYukinori KurokawaOsaka University Clinical Research Group for Gastroenterological Surgery ASO Visual Abstract 01 November 2021 Pages: 933 - 934
Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers Masahiko KuboShogo KobayashiHidetoshi Eguchi Hepatobiliary Tumors 29 September 2021 Pages: 935 - 944
ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis Masahiko KuboShogo Kobayashi ASO Author Reflections 29 September 2021 Pages: 945 - 946
ASO Visual Abstract: Preoperative FDG Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers Masahiko KuboShogo KobayashiHidetoshi Eguchi ASO Visual Abstract 20 October 2021 Pages: 947 - 948
Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis Jun-Yi WuJu-Xian SunMao-Lin Yan Hepatobiliary Tumors 30 September 2021 Pages: 949 - 958
ASO Author Reflections: Impact of Bile Duct Tumor Thrombus in Hepatocellular Carcinoma—Does it Influence Staging Systems? Jun-Yi WuJu-Xian SunMao-Lin Yan ASO Author Reflections 01 October 2021 Pages: 959 - 959
Extended Right Hepatectomy for Hepatocellular Carcinoma F. CrafaS. VanellaI. Apicella Hepatobiliary Tumors 19 August 2021 Pages: 960 - 961
ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence F. CrafaS. VanellaI. Apicella ASO Author Reflections 01 September 2021 Pages: 962 - 963
Robotic Resection of Type I Hilar Cholangiocarcinoma with Intrapancreatic Bile Duct Dissection May C. TeeRushin D. BrahmbhattJan Franko Hepatobiliary Tumors 06 October 2021 Pages: 964 - 969
Intrahepatic Glissonean Approach for Laparoscopic Bisegmentectomy 7 and 8 With Root-Side Hepatic Vein Exposure Kazuteru MondenHiroshi SadamoriNorihisa Takakura Hepatobiliary Tumors 26 November 2021 Pages: 970 - 971
Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes Olga KantorJessica MeansTari A. King Breast Oncology 01 September 2021 Pages: 972 - 980
A Cross-Sectional Study of Distress Levels in Patients with Newly Diagnosed Breast Cancer: The Impact of Race, Ethnicity, and Language Preference Lorena GonzalezCanlan SunVeronica Jones Breast Oncology 28 September 2021 Pages: 981 - 988
Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement Yara W. KassamaniCheryl L. BrunelleAlphonse G. Taghian Breast Oncology 09 September 2021 Pages: 989 - 1002
ASO Author Reflections: Breast Cancer-Related Lymphedema—A Suggested Clinical Pathway for Diagnosis Cheryl L. BrunelleAlphonse G. Taghian ASO Author Reflections 09 September 2021 Pages: 1003 - 1004